We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-2.63%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.26B
AUM Growth
-$529M
Cap. Flow
-$492M
Cap. Flow %
-21.74%
Top 10 Hldgs %
34.63%
Holding
101
New
12
Increased
22
Reduced
23
Closed
23

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$36.9M
2
DXCM icon
DexCom
DXCM
+$32.3M
3
BLUE
bluebird bio
BLUE
+$24.8M
4
ACHC icon
Acadia Healthcare
ACHC
+$24.2M
5
ASND icon
Ascendis Pharma A/S
ASND
+$23.1M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$46.8M
2
BIIB icon
Biogen
BIIB
+$43.1M
3
AZN icon
AstraZeneca
AZN
+$39.1M
4
AXSM icon
Axsome Therapeutics
AXSM
+$32M
5
A icon
Agilent Technologies
A
+$27.5M

Sector Composition

Rank Sector Weight
1 Healthcare 91.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXSM icon
26
Axsome Therapeutics
AXSM
$10.9B
$37.4M 1.65%
606,081
-486,750
-45% -$32M
BDX icon
27
Becton Dickinson
BDX
$46.9B
$37.4M 1.65%
+151,013
New +$36.9M
DVAX
28
DELISTED
Dynavax Technologies
DVAX
$37.3M 1.65%
3,805,370
– –
TMO icon
29
Thermo Fisher Scientific
TMO
$209B
$35.8M 1.58%
62,143
– –
ISEE
30
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$35.7M 1.57%
1,465,483
+547,926
+60% +$12M
UNH icon
31
PUT
UnitedHealth
UNH
$370B
$30.6M 1.35%
+64,700
New +$31.2M
UHS icon
32
Universal Health Services
UHS
$10.2B
$29.7M 1.31%
233,685
+109,264
+88% +$15.1M
WAT icon
33
Waters Corp
WAT
$38.9B
$29.3M 1.29%
94,624
– –
AVTR icon
34
Avantor
AVTR
$9.25B
$28.6M 1.26%
1,351,326
-256,286
-16% -$5.84M
RCUS icon
35
Arcus Biosciences
RCUS
$3.62B
$28.5M 1.26%
1,559,947
-1,143,340
-42% -$21.9M
CRBU icon
36
Caribou Biosciences
CRBU
$156M
$26.6M 1.18%
5,012,118
+552,335
+12% +$3.44M
KRTX
37
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$25.1M 1.11%
138,209
+7,916
+6% +$1.51M
PNT
38
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$23.3M 1.03%
3,204,790
-1,429,012
-31% -$10.6M
LEGN icon
39
Legend Biotech
LEGN
$3.7B
$22.8M 1.01%
+472,161
New +$23.1M
ACHC icon
40
Acadia Healthcare
ACHC
$2.95B
$22.5M 0.99%
+310,935
New +$24.2M
ASND icon
41
Ascendis Pharma A/S
ASND
$16B
$21.7M 0.96%
+202,115
New +$23.1M
THC icon
42
Tenet Healthcare
THC
$20.4B
$21.2M 0.94%
356,941
+102,416
+40% +$5.69M
ICUI icon
43
ICU Medical
ICUI
$4.3B
$20.2M 0.89%
+122,703
New +$21.1M
APLS
44
DELISTED
Apellis Pharmaceuticals
APLS
$18.8M 0.83%
284,269
-34,153
-11% -$1.97M
BCRX icon
45
BioCryst Pharmaceuticals
BCRX
$2.29B
$18M 0.8%
2,162,411
– –
ACLX
46
DELISTED
Arcellx
ACLX
$16.2M 0.72%
525,816
-90,699
-15% -$2.75M
BMRN icon
47
BioMarin Pharmaceuticals
BMRN
$11.7B
$15.5M 0.69%
159,566
-150,835
-49% -$15.6M
ELV icon
48
Elevance Health
ELV
$82B
$15M 0.66%
32,583
-34,532
-51% -$16.4M
BLUE
49
DELISTED
bluebird bio
BLUE
$14.6M 0.64%
229,289
+217,046
+1,773% +$24.8M
ERAS icon
50
Erasca
ERAS
$6.38B
$14.4M 0.64%
4,797,460
– –
1
2
3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q1 2023 Portfolio in Review

As of Q1 2023, PFM Health Sciences held 101 positions worth $2.26B, down 19% from $2.79B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

PFM Health Sciences withdrew a net $492M in Q1 2023, closing 23 positions and reducing 23 holdings. Its most notable exit was Cigna, an estimated $46.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 81% a quarter earlier.

Against the trend, PFM Health Sciences opened a new position in Becton Dickinson worth $37.4M.

  • PFM Health Sciences's largest Q1 2023 buy was Becton Dickinson: 151,013 shares worth $37.4M.
  • PFM Health Sciences added most to DexCom in Q1 2023, an estimated $32.3M increase.
  • PFM Health Sciences's biggest Q1 2023 reduction was Axsome Therapeutics, cutting an estimated $32M.
  • PFM Health Sciences fully exited Cigna in Q1 2023, selling an estimated $46.8M.
  • PFM Health Sciences's ten largest holdings make up 35% of its $2.26B portfolio in Q1 2023.
  • PFM Health Sciences opened 12 new positions and closed 23 in Q1 2023.
  • PFM Health Sciences's portfolio value fell 19% quarter-over-quarter to $2.26B.

Based on PFM Health Sciences's 13F filing for Q1 2023, filed 15 May 2023.